Acute Myelomonocytic Leukemia is a form of acute myeloid leukemia with the proliferation of myeloblasts and monoblasts. Even though Acute Myelomonocytic Leukemia is common form of pediatric cancer, the condition is rare otherwise. If left untreated, this form of cancer will progress very quickly. This disease produced immature white blood cells which do not allow healthy white bloods cells to function properly. Although there are treatments available such as multidrug chemotherapy and bone marrow transplants, the prognosis remains low with a survival rate of 35-60%.
Acute Myelomonocytic Leukemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Myelomonocytic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 2022 products for the study of Acute Myelomonocytic Leukemia that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.